January 21, 2009
NOIDA, India, Jan. 21 -- Jubilant Organosys Ltd, headquartered in Noida near New Delhi, announced today that its subsidiary Jubilant Biosys Ltd., based in Bangalore, has developed a next generation screening solution, Legend NGSS(TM), that will further enable the process of high throughput screening, accelerating global drug discovery. The software to be launched in the [...]
January 21, 2009
Rapiscan Systems, a leading global supplier and manufacturer of security inspection systems for homeland security applications, announced today that its Research and Development division, Rapiscan Laboratories, has received a contract for approximately $2 million from the U.S. Department of Homeland Security’s Domestic Nuclear Detection Office (DNDO). Under the terms of the contract award, the Company [...]
Nanogen Announces Changes in Merger Plans
January 21, 2009
Nanogen, Inc. (Nasdaq: NGEN), developer of in vitro diagnostic products, today announced that it has received permission to investigate alternatives to its announced merger with the Elitech Group. Nanogen requested and Elitech agreed to waive the restrictions in the Share Exchange Agreement related to Nanogen’s right to investigate alternatives because Nanogen and Elitech believe it [...]
January 21, 2009
OSI Systems, Inc. (NASDAQ: OSIS), a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Security division, Rapiscan Systems, has received a contract for approximately $2 million from the U.S. Department of Homeland Security’s Domestic Nuclear Detection Office. Under the terms of the contract award, [...]
KineMatik Group Ltd. Appoints Michael G. Jarjour as President & CEO
January 21, 2009
The KineMatik™ Group LTD (“KineMatik”), providers of software solutions for managing scientific R&D knowledge, information and processes, announced that it has appointed Michael G. Jarjour as President & CEO. Mr. Jarjour, with more than eighteen years of experience in the pharmaceutical research and healthcare technology industries, will lead KineMatik as the company continues to offer [...]
Affordable controlled heating and cooling of round bottom flasks…
January 21, 2009
Radleys, market leader for affordable personal chemistry tools, has launched Breeze, a low cost temperature control system designed to deliver rapid heating and cooling of reactions from -30°C to +165°C. Offering a safer, cleaner and more efficient alternative to using oil or water baths and heating mantles, using the Breeze in conjunction with a Heat-On [...]
January 21, 2009
PerkinElmer, Inc., a global leader focused on the health and safety of people and their environment, today announced that its ViaCord Research Institute™ (VRI™), which focuses on supporting science, technology and medical treatments using cord blood stem cells, will support the University of Massachusetts Medical School (UMMS) in its research efforts into the potential use [...]
January 21, 2009
New Cell Line Products to be Presented at Stem Cells World Conference ALAMEDA, Calif.--BioTime, Inc. (OTCBB:BTIM) Chief Executive Officer Michael West, Ph.D., will deliver a presentation on January 21, 2009 at the Select Biosciences Stem Cells World Congress meeting in Palm Springs, California. Dr. West’s presentation is titled “Embryomics: High Throughput Generation and Mapping of [...]
January 20, 2009
Edinburgh – 20 Jan 2009 - Lab901 today announced shipment of its 50th TapeStation™ instrument to its new Canadian distributor, Inverness Medical. Inverness Medical Canada joins the growing team of international distributors for Lab901’s first ScreenTape® product which automates multiplex PCR detection and analysis. ‘We are delighted to have reached this milestone in such a [...]
January 20, 2009
BEVERLY, Mass.--Hamilton Thorne, Inc. (HT) and Thorlabs, Inc. announced today they have signed an OEM Supply Agreement, which provides HT with OEM and distribution rights for a new confocal imaging system currently under development at Thorlabs. The agreement grants HT the exclusive rights to sell the confocal product to the regenerative medical research market that [...]
